nodes	percent_of_prediction	percent_of_DWPC	metapath
Capreomycin—Induration—Degarelix—prostate cancer	0.0394	0.0394	CcSEcCtD
Capreomycin—Renal tubular necrosis—Conjugated Estrogens—prostate cancer	0.0275	0.0275	CcSEcCtD
Capreomycin—Ototoxicity—Docetaxel—prostate cancer	0.0252	0.0252	CcSEcCtD
Capreomycin—Hypocalcaemia—Estrone—prostate cancer	0.0232	0.0232	CcSEcCtD
Capreomycin—Abscess—Degarelix—prostate cancer	0.0223	0.0223	CcSEcCtD
Capreomycin—Hypocalcaemia—Estradiol valerate/Dienogest—prostate cancer	0.0203	0.0203	CcSEcCtD
Capreomycin—Hypokalaemia—Abiraterone—prostate cancer	0.0143	0.0143	CcSEcCtD
Capreomycin—Induration—Etoposide—prostate cancer	0.0136	0.0136	CcSEcCtD
Capreomycin—Renal impairment—Degarelix—prostate cancer	0.0135	0.0135	CcSEcCtD
Capreomycin—Urine abnormality—Mitoxantrone—prostate cancer	0.0132	0.0132	CcSEcCtD
Capreomycin—Nephropathy toxic—Mitoxantrone—prostate cancer	0.0128	0.0128	CcSEcCtD
Capreomycin—Injection site haemorrhage—Epirubicin—prostate cancer	0.0127	0.0127	CcSEcCtD
Capreomycin—Urine analysis abnormal—Mitoxantrone—prostate cancer	0.0125	0.0125	CcSEcCtD
Capreomycin—Abscess—Conjugated Estrogens—prostate cancer	0.0124	0.0124	CcSEcCtD
Capreomycin—Injection site haemorrhage—Doxorubicin—prostate cancer	0.0117	0.0117	CcSEcCtD
Capreomycin—Hypokalaemia—Cabazitaxel—prostate cancer	0.011	0.011	CcSEcCtD
Capreomycin—Hypocalcaemia—Conjugated Estrogens—prostate cancer	0.0107	0.0107	CcSEcCtD
Capreomycin—Oliguria—Conjugated Estrogens—prostate cancer	0.0107	0.0107	CcSEcCtD
Capreomycin—Nephropathy toxic—Etoposide—prostate cancer	0.0106	0.0106	CcSEcCtD
Capreomycin—Tinnitus—Estramustine—prostate cancer	0.0104	0.0104	CcSEcCtD
Capreomycin—Renal failure—Degarelix—prostate cancer	0.0097	0.0097	CcSEcCtD
Capreomycin—Renal failure—Cabazitaxel—prostate cancer	0.00914	0.00914	CcSEcCtD
Capreomycin—Foetor hepaticus—Docetaxel—prostate cancer	0.00892	0.00892	CcSEcCtD
Capreomycin—Eosinophilia—Bicalutamide—prostate cancer	0.00885	0.00885	CcSEcCtD
Capreomycin—Leukopenia—Estramustine—prostate cancer	0.00871	0.00871	CcSEcCtD
Capreomycin—Hypocalcaemia—Estradiol—prostate cancer	0.00859	0.00859	CcSEcCtD
Capreomycin—Hearing impaired—Estradiol—prostate cancer	0.00826	0.00826	CcSEcCtD
Capreomycin—Hypocalcaemia—Mitoxantrone—prostate cancer	0.008	0.008	CcSEcCtD
Capreomycin—Tinnitus—Cabazitaxel—prostate cancer	0.00778	0.00778	CcSEcCtD
Capreomycin—Thrombocytopenia—Estramustine—prostate cancer	0.00777	0.00777	CcSEcCtD
Capreomycin—Leukopenia—Nilutamide—prostate cancer	0.00772	0.00772	CcSEcCtD
Capreomycin—Hypomagnesaemia—Capecitabine—prostate cancer	0.00772	0.00772	CcSEcCtD
Capreomycin—Leukopenia—Flutamide—prostate cancer	0.00769	0.00769	CcSEcCtD
Capreomycin—Renal impairment—Goserelin—prostate cancer	0.00756	0.00756	CcSEcCtD
Capreomycin—Renal impairment—Conjugated Estrogens—prostate cancer	0.00749	0.00749	CcSEcCtD
Capreomycin—Liver disorder—Docetaxel—prostate cancer	0.00743	0.00743	CcSEcCtD
Capreomycin—Thrombocytopenia—Flutamide—prostate cancer	0.00687	0.00687	CcSEcCtD
Capreomycin—Vertigo—Cabazitaxel—prostate cancer	0.00652	0.00652	CcSEcCtD
Capreomycin—Leukopenia—Cabazitaxel—prostate cancer	0.0065	0.0065	CcSEcCtD
Capreomycin—Hypokalaemia—Conjugated Estrogens—prostate cancer	0.00649	0.00649	CcSEcCtD
Capreomycin—Pain—Estrone—prostate cancer	0.00648	0.00648	CcSEcCtD
Capreomycin—Deafness—Estradiol—prostate cancer	0.00638	0.00638	CcSEcCtD
Capreomycin—Urine abnormality—Epirubicin—prostate cancer	0.00617	0.00617	CcSEcCtD
Capreomycin—Body temperature increased—Abiraterone—prostate cancer	0.00609	0.00609	CcSEcCtD
Capreomycin—Urticaria—Estrone—prostate cancer	0.00602	0.00602	CcSEcCtD
Capreomycin—Pain—Nilutamide—prostate cancer	0.00602	0.00602	CcSEcCtD
Capreomycin—Urine analysis abnormal—Epirubicin—prostate cancer	0.00581	0.00581	CcSEcCtD
Capreomycin—Thrombocytopenia—Cabazitaxel—prostate cancer	0.0058	0.0058	CcSEcCtD
Capreomycin—Urine abnormality—Doxorubicin—prostate cancer	0.00571	0.00571	CcSEcCtD
Capreomycin—Pain—Estradiol valerate/Dienogest—prostate cancer	0.00566	0.00566	CcSEcCtD
Capreomycin—Body temperature increased—Nilutamide—prostate cancer	0.00557	0.00557	CcSEcCtD
Capreomycin—Abscess—Prednisone—prostate cancer	0.00552	0.00552	CcSEcCtD
Capreomycin—Oliguria—Docetaxel—prostate cancer	0.00549	0.00549	CcSEcCtD
Capreomycin—Renal failure—Goserelin—prostate cancer	0.00545	0.00545	CcSEcCtD
Capreomycin—Renal failure—Conjugated Estrogens—prostate cancer	0.0054	0.0054	CcSEcCtD
Capreomycin—Pain—Degarelix—prostate cancer	0.00538	0.00538	CcSEcCtD
Capreomycin—Hypomagnesaemia—Epirubicin—prostate cancer	0.00537	0.00537	CcSEcCtD
Capreomycin—Urine analysis abnormal—Doxorubicin—prostate cancer	0.00537	0.00537	CcSEcCtD
Capreomycin—Hypocalcaemia—Capecitabine—prostate cancer	0.00535	0.00535	CcSEcCtD
Capreomycin—Hearing impaired—Docetaxel—prostate cancer	0.00532	0.00532	CcSEcCtD
Capreomycin—Urticaria—Estradiol valerate/Dienogest—prostate cancer	0.00526	0.00526	CcSEcCtD
Capreomycin—Hearing impaired—Capecitabine—prostate cancer	0.00515	0.00515	CcSEcCtD
Capreomycin—Pain—Cabazitaxel—prostate cancer	0.00507	0.00507	CcSEcCtD
Capreomycin—Hepatocellular injury—Docetaxel—prostate cancer	0.00506	0.00506	CcSEcCtD
Capreomycin—Rash—Estramustine—prostate cancer	0.00501	0.00501	CcSEcCtD
Capreomycin—Dermatitis—Estramustine—prostate cancer	0.005	0.005	CcSEcCtD
Capreomycin—Urticaria—Degarelix—prostate cancer	0.005	0.005	CcSEcCtD
Capreomycin—Thrombocytopenia—Bicalutamide—prostate cancer	0.00498	0.00498	CcSEcCtD
Capreomycin—Body temperature increased—Degarelix—prostate cancer	0.00497	0.00497	CcSEcCtD
Capreomycin—Hypomagnesaemia—Doxorubicin—prostate cancer	0.00497	0.00497	CcSEcCtD
Capreomycin—Hypersensitivity—Estradiol valerate/Dienogest—prostate cancer	0.00488	0.00488	CcSEcCtD
Capreomycin—Rash—Abiraterone—prostate cancer	0.00486	0.00486	CcSEcCtD
Capreomycin—Dermatitis—Abiraterone—prostate cancer	0.00486	0.00486	CcSEcCtD
Capreomycin—Hypokalaemia—Mitoxantrone—prostate cancer	0.00484	0.00484	CcSEcCtD
Capreomycin—Rash—Estrone—prostate cancer	0.00478	0.00478	CcSEcCtD
Capreomycin—Dermatitis—Estrone—prostate cancer	0.00478	0.00478	CcSEcCtD
Capreomycin—Body temperature increased—Cabazitaxel—prostate cancer	0.00469	0.00469	CcSEcCtD
Capreomycin—Leukocytosis—Prednisone—prostate cancer	0.00465	0.00465	CcSEcCtD
Capreomycin—Hypersensitivity—Degarelix—prostate cancer	0.00464	0.00464	CcSEcCtD
Capreomycin—Rash—Nilutamide—prostate cancer	0.00444	0.00444	CcSEcCtD
Capreomycin—Dermatitis—Nilutamide—prostate cancer	0.00444	0.00444	CcSEcCtD
Capreomycin—Rash—Flutamide—prostate cancer	0.00442	0.00442	CcSEcCtD
Capreomycin—Dermatitis—Flutamide—prostate cancer	0.00442	0.00442	CcSEcCtD
Capreomycin—Hypersensitivity—Cabazitaxel—prostate cancer	0.00437	0.00437	CcSEcCtD
Capreomycin—Pain—Bicalutamide—prostate cancer	0.00435	0.00435	CcSEcCtD
Capreomycin—Abscess—Epirubicin—prostate cancer	0.00432	0.00432	CcSEcCtD
Capreomycin—Rash—Estradiol valerate/Dienogest—prostate cancer	0.00417	0.00417	CcSEcCtD
Capreomycin—Dermatitis—Estradiol valerate/Dienogest—prostate cancer	0.00417	0.00417	CcSEcCtD
Capreomycin—Deafness—Docetaxel—prostate cancer	0.00411	0.00411	CcSEcCtD
Capreomycin—Urticaria—Bicalutamide—prostate cancer	0.00404	0.00404	CcSEcCtD
Capreomycin—Renal failure—Mitoxantrone—prostate cancer	0.00403	0.00403	CcSEcCtD
Capreomycin—Body temperature increased—Bicalutamide—prostate cancer	0.00402	0.00402	CcSEcCtD
Capreomycin—Abscess—Doxorubicin—prostate cancer	0.00399	0.00399	CcSEcCtD
Capreomycin—Deafness—Capecitabine—prostate cancer	0.00398	0.00398	CcSEcCtD
Capreomycin—Rash—Degarelix—prostate cancer	0.00397	0.00397	CcSEcCtD
Capreomycin—Dermatitis—Degarelix—prostate cancer	0.00396	0.00396	CcSEcCtD
Capreomycin—Leukopenia—Goserelin—prostate cancer	0.00388	0.00388	CcSEcCtD
Capreomycin—Renal impairment—Docetaxel—prostate cancer	0.00386	0.00386	CcSEcCtD
Capreomycin—Vertigo—Conjugated Estrogens—prostate cancer	0.00386	0.00386	CcSEcCtD
Capreomycin—Hypersensitivity—Bicalutamide—prostate cancer	0.00375	0.00375	CcSEcCtD
Capreomycin—Renal impairment—Capecitabine—prostate cancer	0.00374	0.00374	CcSEcCtD
Capreomycin—Hypocalcaemia—Epirubicin—prostate cancer	0.00373	0.00373	CcSEcCtD
Capreomycin—Oliguria—Epirubicin—prostate cancer	0.00371	0.00371	CcSEcCtD
Capreomycin—Tinnitus—Estradiol—prostate cancer	0.00368	0.00368	CcSEcCtD
Capreomycin—Thrombocytopenia—Goserelin—prostate cancer	0.00346	0.00346	CcSEcCtD
Capreomycin—Hypocalcaemia—Doxorubicin—prostate cancer	0.00345	0.00345	CcSEcCtD
Capreomycin—Oliguria—Doxorubicin—prostate cancer	0.00343	0.00343	CcSEcCtD
Capreomycin—Hepatocellular injury—Epirubicin—prostate cancer	0.00341	0.00341	CcSEcCtD
Capreomycin—Urticaria—Ethinyl Estradiol—prostate cancer	0.00341	0.00341	CcSEcCtD
Capreomycin—Body temperature increased—Ethinyl Estradiol—prostate cancer	0.0034	0.0034	CcSEcCtD
Capreomycin—Renal failure—Etoposide—prostate cancer	0.00335	0.00335	CcSEcCtD
Capreomycin—Hypokalaemia—Capecitabine—prostate cancer	0.00324	0.00324	CcSEcCtD
Capreomycin—Rash—Bicalutamide—prostate cancer	0.00321	0.00321	CcSEcCtD
Capreomycin—Dermatitis—Bicalutamide—prostate cancer	0.0032	0.0032	CcSEcCtD
Capreomycin—Hypersensitivity—Ethinyl Estradiol—prostate cancer	0.00317	0.00317	CcSEcCtD
Capreomycin—Hepatocellular injury—Doxorubicin—prostate cancer	0.00316	0.00316	CcSEcCtD
Capreomycin—Vertigo—Estradiol—prostate cancer	0.00309	0.00309	CcSEcCtD
Capreomycin—Pain—Goserelin—prostate cancer	0.00302	0.00302	CcSEcCtD
Capreomycin—Pain—Conjugated Estrogens—prostate cancer	0.003	0.003	CcSEcCtD
Capreomycin—Hypokalaemia—Prednisone—prostate cancer	0.00288	0.00288	CcSEcCtD
Capreomycin—Leukopenia—Mitoxantrone—prostate cancer	0.00287	0.00287	CcSEcCtD
Capreomycin—Urticaria—Goserelin—prostate cancer	0.00281	0.00281	CcSEcCtD
Capreomycin—Body temperature increased—Goserelin—prostate cancer	0.0028	0.0028	CcSEcCtD
Capreomycin—Renal failure—Docetaxel—prostate cancer	0.00278	0.00278	CcSEcCtD
Capreomycin—Urticaria—Conjugated Estrogens—prostate cancer	0.00278	0.00278	CcSEcCtD
Capreomycin—Body temperature increased—Conjugated Estrogens—prostate cancer	0.00277	0.00277	CcSEcCtD
Capreomycin—Rash—Ethinyl Estradiol—prostate cancer	0.00271	0.00271	CcSEcCtD
Capreomycin—Dermatitis—Ethinyl Estradiol—prostate cancer	0.00271	0.00271	CcSEcCtD
Capreomycin—Renal failure—Capecitabine—prostate cancer	0.0027	0.0027	CcSEcCtD
Capreomycin—Hypersensitivity—Goserelin—prostate cancer	0.00261	0.00261	CcSEcCtD
Capreomycin—Renal impairment—Epirubicin—prostate cancer	0.0026	0.0026	CcSEcCtD
Capreomycin—Hypersensitivity—Conjugated Estrogens—prostate cancer	0.00258	0.00258	CcSEcCtD
Capreomycin—Thrombocytopenia—Mitoxantrone—prostate cancer	0.00256	0.00256	CcSEcCtD
Capreomycin—Renal impairment—Doxorubicin—prostate cancer	0.00241	0.00241	CcSEcCtD
Capreomycin—Pain—Estradiol—prostate cancer	0.0024	0.0024	CcSEcCtD
Capreomycin—Vertigo—Etoposide—prostate cancer	0.00239	0.00239	CcSEcCtD
Capreomycin—Leukopenia—Etoposide—prostate cancer	0.00238	0.00238	CcSEcCtD
Capreomycin—Tinnitus—Capecitabine—prostate cancer	0.00229	0.00229	CcSEcCtD
Capreomycin—Hypokalaemia—Epirubicin—prostate cancer	0.00226	0.00226	CcSEcCtD
Capreomycin—Pain—Mitoxantrone—prostate cancer	0.00223	0.00223	CcSEcCtD
Capreomycin—Rash—Goserelin—prostate cancer	0.00223	0.00223	CcSEcCtD
Capreomycin—Dermatitis—Goserelin—prostate cancer	0.00223	0.00223	CcSEcCtD
Capreomycin—Urticaria—Estradiol—prostate cancer	0.00223	0.00223	CcSEcCtD
Capreomycin—Body temperature increased—Estradiol—prostate cancer	0.00222	0.00222	CcSEcCtD
Capreomycin—Rash—Conjugated Estrogens—prostate cancer	0.00221	0.00221	CcSEcCtD
Capreomycin—Dermatitis—Conjugated Estrogens—prostate cancer	0.00221	0.00221	CcSEcCtD
Capreomycin—Thrombocytopenia—Etoposide—prostate cancer	0.00213	0.00213	CcSEcCtD
Capreomycin—Eosinophilia—Epirubicin—prostate cancer	0.00212	0.00212	CcSEcCtD
Capreomycin—Hypokalaemia—Doxorubicin—prostate cancer	0.00209	0.00209	CcSEcCtD
Capreomycin—Urticaria—Mitoxantrone—prostate cancer	0.00208	0.00208	CcSEcCtD
Capreomycin—Hypersensitivity—Estradiol—prostate cancer	0.00207	0.00207	CcSEcCtD
Capreomycin—Body temperature increased—Mitoxantrone—prostate cancer	0.00207	0.00207	CcSEcCtD
Capreomycin—Leukopenia—Docetaxel—prostate cancer	0.00198	0.00198	CcSEcCtD
Capreomycin—Eosinophilia—Doxorubicin—prostate cancer	0.00196	0.00196	CcSEcCtD
Capreomycin—Vertigo—Capecitabine—prostate cancer	0.00192	0.00192	CcSEcCtD
Capreomycin—Hypersensitivity—Mitoxantrone—prostate cancer	0.00192	0.00192	CcSEcCtD
Capreomycin—Leukopenia—Capecitabine—prostate cancer	0.00192	0.00192	CcSEcCtD
Capreomycin—Renal failure—Epirubicin—prostate cancer	0.00188	0.00188	CcSEcCtD
Capreomycin—Pain—Etoposide—prostate cancer	0.00186	0.00186	CcSEcCtD
Capreomycin—Thrombocytopenia—Docetaxel—prostate cancer	0.00177	0.00177	CcSEcCtD
Capreomycin—Rash—Estradiol—prostate cancer	0.00177	0.00177	CcSEcCtD
Capreomycin—Dermatitis—Estradiol—prostate cancer	0.00177	0.00177	CcSEcCtD
Capreomycin—Renal failure—Doxorubicin—prostate cancer	0.00174	0.00174	CcSEcCtD
Capreomycin—Urticaria—Etoposide—prostate cancer	0.00173	0.00173	CcSEcCtD
Capreomycin—Body temperature increased—Etoposide—prostate cancer	0.00172	0.00172	CcSEcCtD
Capreomycin—Vertigo—Prednisone—prostate cancer	0.00171	0.00171	CcSEcCtD
Capreomycin—Thrombocytopenia—Capecitabine—prostate cancer	0.00171	0.00171	CcSEcCtD
Capreomycin—Rash—Mitoxantrone—prostate cancer	0.00165	0.00165	CcSEcCtD
Capreomycin—Dermatitis—Mitoxantrone—prostate cancer	0.00165	0.00165	CcSEcCtD
Capreomycin—Hypersensitivity—Etoposide—prostate cancer	0.0016	0.0016	CcSEcCtD
Capreomycin—Tinnitus—Epirubicin—prostate cancer	0.0016	0.0016	CcSEcCtD
Capreomycin—Pain—Docetaxel—prostate cancer	0.00154	0.00154	CcSEcCtD
Capreomycin—Pain—Capecitabine—prostate cancer	0.0015	0.0015	CcSEcCtD
Capreomycin—Tinnitus—Doxorubicin—prostate cancer	0.00148	0.00148	CcSEcCtD
Capreomycin—Body temperature increased—Docetaxel—prostate cancer	0.00143	0.00143	CcSEcCtD
Capreomycin—Urticaria—Capecitabine—prostate cancer	0.00139	0.00139	CcSEcCtD
Capreomycin—Body temperature increased—Capecitabine—prostate cancer	0.00138	0.00138	CcSEcCtD
Capreomycin—Rash—Etoposide—prostate cancer	0.00137	0.00137	CcSEcCtD
Capreomycin—Dermatitis—Etoposide—prostate cancer	0.00137	0.00137	CcSEcCtD
Capreomycin—Vertigo—Epirubicin—prostate cancer	0.00134	0.00134	CcSEcCtD
Capreomycin—Leukopenia—Epirubicin—prostate cancer	0.00134	0.00134	CcSEcCtD
Capreomycin—Hypersensitivity—Docetaxel—prostate cancer	0.00133	0.00133	CcSEcCtD
Capreomycin—Hypersensitivity—Capecitabine—prostate cancer	0.00129	0.00129	CcSEcCtD
Capreomycin—Vertigo—Doxorubicin—prostate cancer	0.00124	0.00124	CcSEcCtD
Capreomycin—Urticaria—Prednisone—prostate cancer	0.00124	0.00124	CcSEcCtD
Capreomycin—Leukopenia—Doxorubicin—prostate cancer	0.00124	0.00124	CcSEcCtD
Capreomycin—Body temperature increased—Prednisone—prostate cancer	0.00123	0.00123	CcSEcCtD
Capreomycin—Thrombocytopenia—Epirubicin—prostate cancer	0.00119	0.00119	CcSEcCtD
Capreomycin—Hypersensitivity—Prednisone—prostate cancer	0.00115	0.00115	CcSEcCtD
Capreomycin—Rash—Docetaxel—prostate cancer	0.00114	0.00114	CcSEcCtD
Capreomycin—Dermatitis—Docetaxel—prostate cancer	0.00114	0.00114	CcSEcCtD
Capreomycin—Thrombocytopenia—Doxorubicin—prostate cancer	0.0011	0.0011	CcSEcCtD
Capreomycin—Rash—Capecitabine—prostate cancer	0.0011	0.0011	CcSEcCtD
Capreomycin—Dermatitis—Capecitabine—prostate cancer	0.0011	0.0011	CcSEcCtD
Capreomycin—Pain—Epirubicin—prostate cancer	0.00104	0.00104	CcSEcCtD
Capreomycin—Rash—Prednisone—prostate cancer	0.000982	0.000982	CcSEcCtD
Capreomycin—Dermatitis—Prednisone—prostate cancer	0.000981	0.000981	CcSEcCtD
Capreomycin—Urticaria—Epirubicin—prostate cancer	0.000968	0.000968	CcSEcCtD
Capreomycin—Pain—Doxorubicin—prostate cancer	0.000964	0.000964	CcSEcCtD
Capreomycin—Body temperature increased—Epirubicin—prostate cancer	0.000963	0.000963	CcSEcCtD
Capreomycin—Hypersensitivity—Epirubicin—prostate cancer	0.000898	0.000898	CcSEcCtD
Capreomycin—Urticaria—Doxorubicin—prostate cancer	0.000895	0.000895	CcSEcCtD
Capreomycin—Body temperature increased—Doxorubicin—prostate cancer	0.000891	0.000891	CcSEcCtD
Capreomycin—Hypersensitivity—Doxorubicin—prostate cancer	0.00083	0.00083	CcSEcCtD
Capreomycin—Rash—Epirubicin—prostate cancer	0.000768	0.000768	CcSEcCtD
Capreomycin—Dermatitis—Epirubicin—prostate cancer	0.000767	0.000767	CcSEcCtD
Capreomycin—Rash—Doxorubicin—prostate cancer	0.000711	0.000711	CcSEcCtD
Capreomycin—Dermatitis—Doxorubicin—prostate cancer	0.00071	0.00071	CcSEcCtD
